| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.29 | 5e-07 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |